Loading...
Loading...
By Enrique Culebro - Thu, 10/01/2026 - 05:00
Are Mexican physicians behind, ahead, or simply different from their regional peers? A new study aims to find the answer. Enrique Culebro explains.
https://mexicobusiness.news/tag/pharmaceutical-industry
More Health
By Sergio Arturo Lievano Madrigal - Thu, 08/20/2026 - 15:14
This week: ISSSTE opens a new Tampico hospital, AI reshapes patient adherence and mental health, and Mexico debates its health insurance reform.
By Sergio Arturo Lievano Madrigal - Thu, 08/20/2026 - 15:03
This week: Mexico's labor gap hits 10.4 million, AI exposure reaches 2.9 million formal jobs, and migrant job losses in the US strain remittances.
By Sergio Arturo Lievano Madrigal - Wed, 08/19/2026 - 16:02
Innovation can take the shape of new pharmaceutical formulations and better delivery mechanisms, says Eurofarma’s Marcela Sabaini.
By Hector Salinas - Wed, 08/19/2026 - 07:00
Mexico’s pharma market relies on AI-driven patient adherence, digital tools, and trust to sustain growth amid a volume drop, writes Héctor Salinas.
By Sergio Arturo Lievano Madrigal - Tue, 08/18/2026 - 08:26
Eurofarma ranks as the top pharmaceutical employer for the fifth consecutive year in Great Place To Work's 2026 Best Workplaces in Latin America.
By Sergio Arturo Lievano Madrigal - Thu, 08/13/2026 - 15:57
This week, AI reshaped clinical care, COFEPRIS reset priorities, and new hospital investments advanced. This and more in the weekly roundup!
By Alex Ruiz Bernal - Mon, 08/10/2026 - 09:00
AI empowers patients, shifts healthcare power dynamics, and forces doctors, pharma, and insurers to build trust, writes Alejandro Ruiz.
By Sergio Arturo Lievano Madrigal - Thu, 08/06/2026 - 16:33
AstraZeneca-Bristol Myers merger talks, Oaxaca's new hospital complex, and an accelerating Ebola outbreak headline this week's health news.
By Sergio Arturo Lievano Madrigal - Mon, 08/03/2026 - 11:48
AstraZeneca and Bristol Myers Squibb hold merger talks for a possible US$400 billion deal, say sources.
By Sergio Arturo Lievano Madrigal - Mon, 07/27/2026 - 17:06
COFEPRIS and CONBIOÉTICA briefed Mexico's clinical research sector on the General Health Law reform, aiming to speed reviews.
